Additionally, swertiamarin has been shown to enhance fatty acid β-oxidation through activation of 3-ketoacyl-coA thiolase, and preventing HFD-induced lipid deposition and hyperlipidaemia [25]. Here, HADHB is linked to hyperlipidemia.